360 million dollars is the incredible sum that Samsung will spend in the next five years to become the giant in the manufacture of chips and drugs.
From washing machines to smartphones and televisions, Samsung is unquestionably the consumer electronics giant of reference in the world due to the diversity of its activities and its ability to offer innovations in each area. This diversity, Samsung will maintain it with massive new investments. The group announced an investment of 450 trillion won, or about $360 billion.
This sum will be spent in a few years, by 2026, to develop two activities of Samsung: the manufacture of chips and medicine. This should result in the creation of 80,000 jobs in the semiconductor and pharmaceutical industries.
Compete with TSMC and Intel
Samsung therefore wants to spend more than $100 billion to develop its chip manufacturing infrastructure. We have already seen the firm obtain contracts, in particular with Nvidia, to manufacture its graphics cards, or with Qualcomm for Snapdragon.
In the midst of a shortage of components, the high tech sector needs chipmakers more than ever and Samsung intends to seize this opportunity. Intel has also decided to redouble its efforts to become competitive again in the face of the lead taken by TSMC. The latter is the heyday of Apple and AMD in particular. For Samsung, the objective is to rely on the future 3 nm chip market.
Samsung did not give more details on its investments in the pharmaceutical sector, except that it will go through its subsidiaries Samsung Biologics and Samsung Bioepis.
To follow us, we invite you to download our Android and iOS application. You can read our articles, files, and watch our latest YouTube videos.